Results 311 to 320 of about 251,408 (329)

Prednisone

Reactions Weekly, 2021
openaire   +1 more source

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Lancet Oncology, The, 2019
Daniel J Khalaf, Matti Annala, Sinja Taavitsainen   +2 more
exaly  

Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma

Journal of Clinical Oncology, 2008
Robert Marcus, David Cunningham
exaly  

Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial

The Lancet, 2015
C. Blum, Nicole Nigro, M. Briel, P. Schuetz, E. Ullmer, I. Suter‐Widmer, B. Winzeler, R. Bingisser, H. Elsaesser, D. Drozdov, Birsen Arici, S. Urwyler, J. Refardt, P. Tarr, S. Wirz, R. Thomann, C. Baumgartner, H. Duplain, D. Burki, Werner Zimmerli, Nicolas Rodondi, B. Mueller, M. Christ-Crain   +22 more
semanticscholar   +1 more source

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

Lancet Oncology, The, 2015
Francesca Gay, Stefania Oliva, Maria Teresa Petrucci   +2 more
exaly  

A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study

Acta Haematologica, 2016
J. Matschke, H. Müller-Beissenhirtz, J. Novotny, Ilona Vester, B. Hertenstein, L. Eisele, H. Lax, C. Ose, U. Dührsen   +8 more
semanticscholar   +1 more source

Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)

Journal of Clinical Oncology, 2005
Eva Hoster, Bernd Metzner
exaly  

Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial

Journal of Clinical Oncology, 2009
Phillipe Moreau
exaly  

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

Lancet Oncology, The, 2010
María-Victoria Mateos, Albert Oriol, Felipe de Arriba   +2 more
exaly  

Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial

Lancet, The, 2008
Frank Buttgereit, Rieke E Alten
exaly